![Parkinson's patient Steve Spencer and his wife Kae, who both participated in the patient guide "Navigating Clinical Trials."](/sites/default/files/styles/hero_xl/public/images/hero/join-a-study-image-header.jpg?h=44d298b0&itok=SO1K-k-H)
![Parkinson's patient Steve Spencer and his wife Kae, who both participated in the patient guide "Navigating Clinical Trials."](/sites/default/files/styles/hero_xl/public/images/hero/join-a-study-image-header.jpg?h=44d298b0&itok=SO1K-k-H)
You have the power to propel research toward Parkinson’s breakthroughs and, ultimately, a cure. No amount of funding or other resources can make up for a lack of volunteers in Parkinson’s research.
Find the Right Trial for You
![Illustrated PPMI logo.](/sites/default/files/styles/content_with_image_item/public/images/module/orange-PPMI.png?h=d70dd8e3&itok=qCEiAjBe)
Parkinson's Progression Markers Initiative
Our landmark study seeks to transform how we diagnose, track, treat and potentially prevent Parkinson’s disease.
- The study needs people with and without Parkinson's disease
- People recently diagnosed with Parkinson's and people with Parkinson's risk factors can play a critical role
![Illustrated Michael J. Fox Foundation logo.](/sites/default/files/styles/content_with_image_item/public/images/module/orange-fox-trial-finder.png?h=d70dd8e3&itok=uRUMA9Vg)
Fox Trial Finder
Our revamped user-friendly online matching tool helps you find observational studies and clinical trials in your area.
- People with and without Parkinson's can participate
- Review studies that match your location and traits
- Securely connect with researchers
- Sign up for emails about new trials through iConnect
![Illustrated Fox Insight logo.](/sites/default/files/styles/content_with_image_item/public/images/module/orange-fox-insight.png?h=d70dd8e3&itok=pB3diCn3)
Fox Insight
Our online clinical study collects self-reported data to learn more about life with Parkinson's.
- People with and without the disease can participate
- Complete online questionnaires
85 percent of trials face delays and 30 percent never get off the ground because of a lack of volunteers, resulting in a dramatic slowdown in progress toward a cure.